Prescribing Trends in Psychotropic Medications
Open Access
- 18 February 1998
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 279 (7) , 526-531
- https://doi.org/10.1001/jama.279.7.526
Abstract
PSYCHOTROPIC MEDICATIONS are among the most widely prescribed medications in the United States. As a class, they represented 8.8% of the prescription drug market in 1994,1 and their use has been increasing in recent years. A number of studies have documented differences over time and among physician groups in the use of psychotropic medications.2,3 In 1993, Olfson and Klerman4 reported a number of changes in the prescription patterns of psychotropic medications among office-based physicians. Their analyses revealed that between 1980 and 1989 the total number of office visits that included the prescription of a psychotropic drug remained relatively stable. They noted a decrease in the proportion of these visits to primary care physicians and an increase in the proportion of these visits to psychiatrists. However, recent years have seen enormous changes in the health care system and in the availability and applications of new and older psychotropic drugs.Keywords
This publication has 6 references indexed in Scilit:
- More Frequent Diagnosis of Attention Deficit–Hyperactivity DisorderNew England Journal of Medicine, 1995
- Stimulant Medications and the Treatment of Children with ADHDPublished by Springer Nature ,1995
- Benzodiazepines in the treatment of schizophrenia: a review and reappraisalAmerican Journal of Psychiatry, 1991
- Assessing the effects of physician payment on treatment of mental disorders in primary careGeneral Hospital Psychiatry, 1990
- Prescribing of Psychotropic Medication by Primary Care Physicians and PsychiatristsArchives of General Psychiatry, 1988
- The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basisAmerican Journal of Psychiatry, 1988